Administrative Core

行政核心

基本信息

  • 批准号:
    10661810
  • 负责人:
  • 金额:
    $ 10.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Administrative Core Summary/Abstract The overall goal of the Administrative Core is to maximize integration of all projects and cores, and collaborations among Program Investigators and Core leaders. This Core is essential for coordinating the scientific, financial, organizational, and monitoring activities, and facilitating inter-project interactions of this multi-project grant to maximize the success of the overall multi-project research program. The Core will be led by Dr. Elizabeth Jaffee, who has extensive experience overseeing scientific programs at the Sidney Kimmel Cancer Center at Johns Hopkins, as well as a number of multi-project NIH funded programs. Dr. Jaffee recently served as the Team Leader for a multi-site, multiple principal investigator grant through Stand Up To Cancer. Dr. Daniel Laheru will serve as co-leader of this Core. Dr. Laheru brings many years of experience conducting clinical trials in pancreatic cancer and serves as the co- director of the Gastrointestinal Cancer program and co-director of the Skip Viragh Pancreatic Cancer Center for Clinical Research and Clinical Care. The specific aims are to: 1) Provide organizational and administrative management to insure success of all projects and cores within the program; and 2) Facilitate scientific collaborations and program oversight through the coordination of scientific and advisory board meetings for the investigators in this program. Drs. Jaffee and Laheru will monitor progress of all Projects and Cores, identify challenges or hurdles, and assist with problem solving. The Administrative Assistant to Drs. Jaffee and Laheru, will be responsible for oversight of the distribution and usage of funding provided to the individual programs and Cores. She will also provide monthly financial reports for all projects and cores within the program, assist investigators with non-competitive renewal applications, and provide support for manuscript preparation and submission. Drs. Jaffee and Laheru will convene weekly scientific meetings for all members of the Program Project, and monthly meetings of Project and Core Leaders to ensure adequate communication between and integration of all Project and Core teams. There will also be quarterly meetings with the internal advisory board to monitor and provide input on the group’s scientific progress. In addition, there will be an annual one-day scientific retreat to include all investigators and the internal and external scientific advisors. A closed advisory board meeting will be held at the conclusion of the retreat for the advisors to provide objective feedback to the program investigators.
行政核心摘要/摘要 管理核心的总体目标是最大限度地集成所有项目和核心,并且 项目研究者和核心领导者之间的合作对于协调至关重要。 科学、财务、组织和监测活动,并促进项目间互动 该多项目资助的目的是最大限度地提高整个多项目研究计划的成功。 Core 将由 Elizabeth Jaffee 博士领导,她在监督科学项目方面拥有丰富的经验 约翰·霍普金斯大学悉尼金梅尔癌症中心以及 NIH 资助的多个多项目 Jaffee 博士最近担任多地点、多个首席研究员的团队负责人。 Daniel Laheru 博士将担任该核心的联合领导者。 带来了多年进行胰腺癌临床试验的经验,并担任联合 胃肠癌项目主任兼 Skip Viragh 胰腺癌联合主任 临床研究和临床护理中心。 具体目标是: 1)提供组织和行政管理以确保成功 该计划内的所有项目和核心;以及 2) 促进科学合作和计划 通过协调科学和咨询委员会会议对调查人员进行监督 程序。 Jaffee 和 Laheru 博士将监控所有项目和核心的进展,找出挑战或障碍, 并协助 Jaffee 和 Laheru 博士解决问题。 负责监督各项目资金的分配和使用 她还将提供该计划内所有项目和核心的月度财务报告, 协助研究者进行非竞争性续展申请,并为稿件提供支持 准备和提交。 Jaffee 和 Laheru 博士将为该计划的所有成员每周召开一次科学会议, 项目和核心领导者每月举行会议,以确保项目和核心领导者之间充分沟通 所有项目和核心团队的整合还将与内部人员举行季度会议。 此外,还将设立顾问委员会来监督该小组的科学进展并提供意见。 每年一次为期一天的科学务虚会,包括所有研究人员以及内部和外部科学人员 顾问务虚会结束时将举行一次闭门顾问委员会会议。 向计划调查人员提供客观反馈。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELIZABETH M. JAFFEE其他文献

ELIZABETH M. JAFFEE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELIZABETH M. JAFFEE', 18)}}的其他基金

Transforming Human Pancreatic Cancer Into An Immunologic Disease
将人类胰腺癌转变为免疫疾病
  • 批准号:
    10408080
  • 财政年份:
    2021
  • 资助金额:
    $ 10.02万
  • 项目类别:
Integration of neo-antigen vaccines and immune checkpoint therapy
新抗原疫苗与免疫检查点疗法的整合
  • 批准号:
    10408081
  • 财政年份:
    2021
  • 资助金额:
    $ 10.02万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10408086
  • 财政年份:
    2021
  • 资助金额:
    $ 10.02万
  • 项目类别:
Transforming Human Pancreatic Cancer Into An Immunologic Disease
将人类胰腺癌转变为免疫疾病
  • 批准号:
    10661794
  • 财政年份:
    2021
  • 资助金额:
    $ 10.02万
  • 项目类别:
Integration of neo-antigen vaccines and immune checkpoint therapy
新抗原疫苗与免疫检查点疗法的整合
  • 批准号:
    10661795
  • 财政年份:
    2021
  • 资助金额:
    $ 10.02万
  • 项目类别:
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
利用新辅助平台针对胰腺癌免疫抑制肿瘤微环境的临床试验
  • 批准号:
    10407582
  • 财政年份:
    2015
  • 资助金额:
    $ 10.02万
  • 项目类别:
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
利用新辅助平台针对胰腺癌免疫抑制肿瘤微环境的临床试验
  • 批准号:
    10654572
  • 财政年份:
    2015
  • 资助金额:
    $ 10.02万
  • 项目类别:
Reprogramming the pancreatic tumor microenvironment with immunotherapy
用免疫疗法重新编程胰腺肿瘤微环境
  • 批准号:
    9306033
  • 财政年份:
    2015
  • 资助金额:
    $ 10.02万
  • 项目类别:
Reprogramming the pancreatic tumor microenvironment with immunotherapy
用免疫疗法重新编程胰腺肿瘤微环境
  • 批准号:
    8941804
  • 财政年份:
    2015
  • 资助金额:
    $ 10.02万
  • 项目类别:
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
(PQB-3) 驱动基因诱导的胰腺癌发展中的炎症
  • 批准号:
    9042316
  • 财政年份:
    2014
  • 资助金额:
    $ 10.02万
  • 项目类别:

相似海外基金

Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
  • 批准号:
    10752046
  • 财政年份:
    2024
  • 资助金额:
    $ 10.02万
  • 项目类别:
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
  • 批准号:
    10748859
  • 财政年份:
    2024
  • 资助金额:
    $ 10.02万
  • 项目类别:
Core B: Clinical Trials Core
核心 B:临床试验核心
  • 批准号:
    10554476
  • 财政年份:
    2023
  • 资助金额:
    $ 10.02万
  • 项目类别:
Applying Population Management Best Practices to Preventive Genomic Medicine
将人口管理最佳实践应用于预防性基因组医学
  • 批准号:
    10674202
  • 财政年份:
    2023
  • 资助金额:
    $ 10.02万
  • 项目类别:
Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH)
创新的快速、经济、即时护理 HPV 自检策略 (I-REACH)
  • 批准号:
    10648634
  • 财政年份:
    2023
  • 资助金额:
    $ 10.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了